M. L. Bravo

Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor

M. Cuello, C. Lange, M. Pinto, 2015, Endocrine.

A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability

J. Torres, Matías Muñoz-Medel, M. Córdova-Delgado, 2020, Cancers.

2-Methoxyestradiol Inhibits Progesterone-Dependent Tissue Factor Expression and Activity in Breast Cancer Cells

J. Brosens, M. Cuello, C. Lange, 2010, Hormones & cancer.

Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective

J. Torres, M. Córdova-Delgado, I. Retamal, 2018, Hormones and Cancer.

Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer.

R. Gejman, Matías Muñoz-Medel, M. Córdova-Delgado, 2020, Clinical lung cancer.

Cytoprotective Activity in the Gastric Mucosa of Rats Exposed to Carbon Tetrachloride-Induced Liver Injury

O. Bulbena, M. L. Bravo, J. Culat, 1997, Inflammation.

First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution

H. Galindo, B. Nervi, J. Madrid, 2020, Current medical research and opinion.

Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI

M. Cuello, A. Quest, G. Owen, 2011, Journal of cellular physiology.

Gastrotoxic activity and inhibitory effects on gastric mucosal PGE2 production with different non-steroidal anti-inflammatory drugs: modifications induced by pretreatment with zinc acexamate.

O. Bulbena, M. L. Bravo, C. Navarro, 1994, Prostaglandins, leukotrienes, and essential fatty acids.